Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 6, 2015
Pharmacy Choice - News - Generic Drugs - March 6, 2015

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 59     Next >>     Go To Page:

3/6/15 - Actavis Receives Final Approval for Generic Version of Subutex
By a News Reporter-Staff News Editor at Health& Medicine Week Actavis plc announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex. Actavis intends to begin shipping its product shortly. Keywords for this news article inclu
3/6/15 - New Health Economics Findings Has Been Reported by Investigators at Office of Health Economics (Pharmaceutical Pricing In Emerging Markets: Effects...
New Health Economics Findings Has Been Reported by Investigators at Office of Health Economics. According to news reporting out of London, United Kingdom, by NewsRx editors, research stated, "This paper analyzes determinants of ex-manufacturer prices for originator and generic drugs across countries. Our news journalists obtained a quote from the r
3/5/15 - Analyzing the Global Pharmaceutical Industry 2015
The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues with intercontinental treatment demand of patients being serviced from often one or two mega research centers in the continent. By contribut
3/5/15 - ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals
ANI Pharmaceuticals, Inc. today announced that it has acquired the approved abbreviated new drug application for Flecainide Acetate tablets USP 50 mg, 100 mg and 150 mg, previously marketed by Teva Pharmaceuticals. Arthur S. Przybyl, President and CEO of ANI Pharmaceuticals, stated, "This acquisition further expands our near-term generic pipeline
3/5/15 - CEGEDIM STRATEGIC DATA : Worldwide Pharma Industry Sales Force Levels Flat in 201
China was the exception showing double digit growth of sales force levels of 11.4% with some 111,000 FTEs measured as of Q4, 2014. Brazil also saw an increase, although at a slower rate compared to 2013, with over 29,000 reps through 2014, up 2.4%. The opposite appears to be the case for Japan however as generic penetration is set to dramatically a
3/5/15 - Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing; Request for Comments
FDA is seeking this input from a variety of stakeholdersindustry, academia, patient advocates, professional societies, and other interested partiesas it fulfills its commitment under the Generic Drug User Fee Amendments of 2012 to develop an annual list of regulatory science initiatives specific to generic drugs. FDA will take the information i
3/5/15 - India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics
has announced the addition of the "India Pharma Outlook 2015: Accelerating growth to the next level- Moving up the value chain beyond Generics" report to their offering. Sun's in-licensing of biologics from Merck also indicates, Indian companies willingness to advance its pipeline towards upper value chain. Though, US market remains the largest mar
3/5/15 - Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives
Dublin- Research and Markets has announced the addition of the "Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics, Biosimilars and Overseas Strategic Initiatives" report to their offering. The new pricing system adopted in Japan from April -2014 is a game changer initiative. The format and regulations for AG's are still not clear
3/5/15 - Research and Markets: India Pharma Outlook 2015: Accelerating Growth to the Next Level - Moving Up the Value Chain Beyond Generics
Research and Markets has announced the addition of the " India Pharma Outlook 2015: Accelerating growth to the next level- Moving up the value chain beyond Generics" report to their offering. Though, US market remains the largest market for India generic exports, it is witnessing a slowdown in product approvals and channel consolidation which has i
3/5/15 - Research and Markets: Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives
Research and Markets has announced the addition of the " Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics, Biosimilars and Overseas Strategic Initiatives" report to their offering. The new pricing system adopted in Japan from April -2014 is a game changer initiative. The format and regulations for AG's are still not clear in Jap
3/5/15 - Safeguard Scientifics Announces Fourth Quarter and Full-Year 2014 Financial Results
Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2014 financial results. For the three months ended December 31, 2014, Safeguard's net loss was $15.1 million, or $0.73 per share, compared to net income of $24.0 million, or $1.10 per share for the same period in 2013. For the year ended December 31, 2014, Safeguard's net loss
3/5/15 - Teva to Present at the Barclays Global Healthcare Conference
Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Barclays Global Healthcare Conference in Miami, FL. Eyal Desheh, Group EVP& CFO will present on Thursday, March 12, 2015 at 8:30 AM ET. Headquartered in Israel, Teva is the world s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to
3/5/15 - U.S. Biosimilar Approvals Poised to Grow, but Market Uptake Faces Several Challenges, According to the Tufts Center for the Study of Drug Development
Biosimilar approvals in the United States are expected to increase during the next five years, but safety concerns among physicians and the need for greater regulatory clarity concerning therapeutic interchangeability could hinder market uptake, according to a study recently completed by the Tufts Center for the Study of Drug Development.
3/4/15 - Actavis Confirms District Court Ruling In Atelvia Patent Litigation
Actavis plc, headquartered in Dublin, Ireland, is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world. Actavis markets a broad portfolio of branded and generic pharmaceuticals and develops...
3/4/15 - ANI Pharmaceuticals To Present At 27th Annual ROTH Conference
ANI Pharmaceuticals, Inc. announced today that it will present at the 27th Annual ROTH Conference at the Ritz-Carlton at Laguna Niguel, California. On March 9, 2015 at 11 AM PT, Arthur S. Przybyl, President and CEO, will give the Company's presentation, which is posted on the Investor section of ANI's website at www.anipharmaceuticals.com. ANI Ph
3/4/15 - Biologics, Biosimilars and Biobetters: Strategies for Nonclinical Safety Testing, New Webinar Hosted by Xtalks
By a News Reporter-Staff News Editor at Biotech Week This webinar will discuss new Biologics, Biosimilars, and Biobetters programs using case studies to illustrate strategy choices and the similarities and differences between each program. Join speakers Judith Newmark, Program Manager, Pharmacology/Toxicology/Ocular at Toxikon Corporation, and...
3/4/15 - Global Biologics and Biosimilars Industry Report 2015
Dublin- Research and Markets has announced the addition of the " Global Biologics and Biosimilars Industry Report 2015" report to their offering. The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the biologics and biosimilars industry. The report provides a basic overview of the i
3/4/15 - Global Biologics and Biosimilars Industry Report 2015 - Forecasts to 2020
Research and Markets has announced the addition of the " Global Biologics and Biosimilars Industry Report 2015" report to their offering. The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the biologics and biosimilars industry. The report provides a basic overview of the industr
3/4/15 - Global Biologics and Biosimilars Industry Report 2015-2020
has announced the addition of the " Global Biologics and Biosimilars Industry Report 2015" report to their offering. The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the biologics and biosimilars industry. The report provides a basic overview of the industry including definitions
3/4/15 - Global Biosimilars Market - Size, Share, Trends Analysis and Industry Forecast 2020
Persistence Market Research is released upcoming report on title "Biosimilars Market- Global Industry Analysis and Forecast to 2020". New York, NY 03/04/2015 Biosimilars or follow-on biologics are biopharmaceutical drugs that are similar to approved biological drugs. Biosimilars are different from other generic drugs in terms of raw material
3/4/15 - HYPERION THERAPEUTICS INC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following management's discussion and analysis should be read in conjunction with our audited consolidated financial statements and related notes that appear elsewhere in this Annual Report on Form 10- K. This Management's Discussion and Analysis contains forward-looking statements that involve risks and uncertainties. Please see "Special Note.
3/4/15 - Import of generic drugs to Kyrgyzstan now legal [AKIpress News Agency (Kyrgyz Republic)]
Members of the parliament of Kyrgyzstan approved on March 4 the third reading of the amendments to the patent act. The bill was prepared to give population an access to generic drugs. Prices for medicines in Kyrgyzstan mainly depend on the system of intellectual property rights, which makes them too expensive, the bill initiators said.
3/4/15 - Japan Pharma Outlook 2015: 2015 Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives, New Report Launched
Market Research Reports, Inc. has announced the addition of Japan Pharma Outlook 2015: 2015 Year to Watch out for Authorized Generics, Biosimilars and Overseas Strategic Initiatives research report to their website http://www.MarketResearchReports.comLewes, DE 03/04/2015 The new pricing system adopted in Japan from April -2014 is a g
3/4/15 - Pharmaceutical Directory of India 2015
Dublin- Research and Markets has announced the addition of the "Pharmaceutical Directory of India 2015" directory to their offering. This is further triggered by the fact that generics worth over $40 billion are going off patent in the coming few years which is close to 15% of the total prescription market of the US. If you need to source from, or
3/4/15 - Research and Markets: Global Biologics and Biosimilars Industry Report 2015
Research and Markets has announced the addition of the " Global Biologics and Biosimilars Industry Report 2015" report to their offering. The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the biologics and biosimilars industry. The report provides a basic overview of the industry.
Articles(s): 1 - 25 of 59     Next >>     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part II: Psychiatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415